https://www.selleckchem.com/pr....oducts/l-alpha-phosp
When this Special Issue was launched, we cast the net widely in terms of the subject matter we considered suitable for the papers. We stated that papers on "well-established unit operations such as heat treatments and membrane separation in addition to emerging technologies" would be welcomed. The seven papers accepted do, indeed, cover a range of topics including UHT milk, proteolytic digestion, membrane technologies, cheese and yogurt. Three papers [...].Chronic myeloid leukaemia (CML) is currently treated with inh
Like
Comment
Share
